Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Cash from Investing Activities (2019 - 2025)

Inventiva (IVA) posted quarterly Cash from Investing Activities of -$28.1 million for Q2 2025, down 10166.56% quarter-over-quarter from -$273426.3 in Q4 2022.

Analysis

Inventiva (IVA) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Inventiva's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$28.1 million for Q2 2025.

  • In Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$28.1 million; the TTM figure through Jun 2025 stood at -$23.2 million (changed N/A YoY), while the FY2025 annual figure was -$155.1 million, down 1759.21% from the prior year.
  • Cash from Investing Activities for Q2 2025 stood at -$28.1 million, down from -$273426.3 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $7.7 million in Q1 2021, with the low at -$28.1 million in Q2 2025.
  • The 3-year median for Cash from Investing Activities is -$276534.1 (2022), against an average of -$2.9 million.
  • The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities surged 553.88% in 2021, then slumped 105.04% in 2022.
  • Inventiva's Cash from Investing Activities stood at $5.4 million in 2021, then plunged by 105.04% to -$273426.3 in 2022, then tumbled by 10166.56% to -$28.1 million in 2025.
  • Business Quant data shows IVA's Cash from Investing Activities at -$28.1 million in Q2 2025, -$273426.3 in Q4 2022, and -$279641.8 in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -28.07 Mn
Dec 31, 2022 -273,426.29
Sep 22, 2022 -279,641.81
Dec 31, 2021 5.42 Mn
Jun 30, 2021 -1.97 Mn
Mar 31, 2021 7.69 Mn
Dec 31, 2020 -1.19 Mn
Dec 31, 2019 -928,678.76